GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Shiller PE Ratio

GeneOne Life Science (XKRX:011000) Shiller PE Ratio : (As of May. 11, 2024)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


GeneOne Life Science Shiller PE Ratio Historical Data

The historical data trend for GeneOne Life Science's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Shiller PE Ratio Chart

GeneOne Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GeneOne Life Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GeneOne Life Science's Shiller PE Ratio

For the Biotechnology subindustry, GeneOne Life Science's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GeneOne Life Science's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneOne Life Science's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GeneOne Life Science's Shiller PE Ratio falls into.



GeneOne Life Science Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GeneOne Life Science's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, GeneOne Life Science's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-511/118.8477*118.8477
=-511.000

Current CPI (Dec. 2023) = 118.8477.

GeneOne Life Science Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -67.909 99.253 -81.316
201406 -262.873 99.353 -314.453
201409 -207.374 99.608 -247.429
201412 -617.356 99.098 -740.392
201503 -25.266 99.720 -30.112
201506 -27.650 100.050 -32.845
201509 105.832 100.110 125.641
201512 -10.965 100.220 -13.003
201603 -36.231 100.560 -42.820
201606 -154.935 100.790 -182.693
201609 -139.680 101.460 -163.618
201612 -134.913 101.560 -157.878
201703 -149.691 102.850 -172.975
201706 -236.931 102.610 -274.425
201709 -116.311 103.490 -133.571
201712 -153.177 102.990 -176.762
201803 -74.252 104.100 -84.771
201806 -76.329 104.130 -87.117
201809 -72.175 105.650 -81.191
201812 -71.656 104.350 -81.611
201903 -11.423 104.490 -12.993
201906 -98.137 104.880 -111.207
201909 -9.346 105.200 -10.558
201912 -91.150 105.120 -103.053
202003 -41.099 105.540 -46.281
202006 -70.701 104.870 -80.124
202009 -37.279 106.200 -41.719
202012 -137.564 105.765 -154.580
202103 -26.352 107.357 -29.172
202106 -89.983 107.579 -99.409
202109 -78.414 108.759 -85.688
202112 -19.252 109.676 -20.862
202203 -60.000 111.806 -63.779
202206 -141.000 114.083 -146.889
202209 -102.000 114.831 -105.568
202212 -189.000 115.200 -194.984
202303 -170.000 116.550 -173.352
202306 -171.000 117.140 -173.493
202309 -148.000 119.111 -147.673
202312 -511.000 118.848 -511.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GeneOne Life Science  (XKRX:011000) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


GeneOne Life Science Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of GeneOne Life Science's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneOne Life Science (XKRX:011000) Business Description

Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science (XKRX:011000) Headlines

No Headlines